The University of Arizona

Study of Lebrikizumab

Summary: 

A study of the effectiveness and safety of Lebrikizumab in treating patients with Idiopathic Pulmonary Fibrosis.

Sponsor: 
Hoffmann-La Roche

Researchers: 

Research Specialties: 
Pulmonary